Product Program year 2025 Source: CMS Open Payments

Venaseal

Device EndoVenous Therapies

PDI 10884521539921

Open in the dashboard

General payments

$2,524,340

23,806 payments

Research payments

$1,694,883

247 payments

Through program year 2025, $2,524,340 in general payments and $1,694,883 in research payments were reported against Venaseal (EndoVenous Therapies).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $519,334 5,976
2025 Research $279,338 62
2024 General $754,937 5,873
2024 Research $259,340 47
2023 General $587,281 6,167
2023 Research $461,657 63
2022 General $662,788 5,790
2022 Research $694,548 75

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $2,524,340 23,806 payments
Top recipients General payments · program year 2025
  1. Kathleen Gibson Vascular Surgery · Bellevue, WA $38,336 7% · 19 payments
  2. Kathleen Ozsvath Vascular Surgery · Albany, NY $18,752 4% · 45 payments
  3. Jon George Interventional Cardiology · Philadelphia, PA $17,331 3% · 19 payments
  4. Ramona Gupta Vascular & Interventional Radiology · Chicago, IL $15,118 3% · 34 payments
  5. Robert Edwards Surgery · Columbus, GA $14,780 3% · 36 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $135,159 26% · 387 practitioners
  2. Interventional Cardiology Internal Medicine $68,775 13% · 186 practitioners
  3. Vascular & Interventional Radiology Radiology $49,393 10% · 93 practitioners
  4. Surgery $42,079 8% · 145 practitioners
  5. Cardiovascular Disease Internal Medicine $38,940 8% · 196 practitioners

The top 5 of 85 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $61,695 12% · 467 recipients
  2. Washington $43,290 8% · 54 recipients
  3. California $41,937 8% · 316 recipients
  4. New York $37,450 7% · 162 recipients
  5. Illinois $34,845 7% · 123 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

23,806 general · 247 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record